EPISODE · Aug 31, 2025 · 1 MIN
Assessing individual cancer characteristics is needed to determine resistance to new types of therapies, Elizabeth Tracey reports
Immunotherapies hold enormous promise for treating cancers of various types, but the bad news is that while many patients may initially respond many will also become resistant. Valsamo Anagnostou, a cancer researcher at Johns Hopkins, is looking at tumor specific … Assessing individual cancer characteristics is needed to determine resistance to new types of therapies, Elizabeth Tracey reports Read more →
Embed this episode
NOW PLAYING
Assessing individual cancer characteristics is needed to determine resistance to new types of therapies, Elizabeth Tracey reports
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.